Scientific breakthrough on objective diagnosis of PTSD
June 26, 2017 10:40 ET
|
Medibio Limited
Scientific breakthrough for non-invasive, automatic, objective diagnosis of PTSD leveraging autonomic biomarkersAccuracy of 80% (+/- 1%) for objectively diagnosing subjects with PTSDMedibio has...
Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression
June 22, 2017 17:12 ET
|
Brainsway Ltd.
HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today...
CORRECTING and REPLACING – Brainsway Reports Strong Momentum in Q1 for 2017
June 08, 2017 17:09 ET
|
Brainsway Ltd.
HACKENSACK, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline on June 6th by Brainsway Ltd. (TASE:BRIN), please note in the fifth paragraph, the third...
Brainsway Reports Strong Momentum in Q1 for 2017
June 06, 2017 13:20 ET
|
Brainsway Ltd.
HACKENSACK, N.J., June 06, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced...
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder
May 17, 2017 16:05 ET
|
Neuralstem, Inc.
GERMANTOWN, Md., May 17, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, today announced it has...
Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update
May 10, 2017 16:05 ET
|
Neuralstem, Inc.
GERMANTOWN, Md., May 10, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, reported its financial...
New Patent on Software as a Therapeutic for Depression and other Disorders
April 18, 2017 08:00 ET
|
Posit Science
SAN FRANCISCO, April 18, 2017 (GLOBE NEWSWIRE) -- The US Patent Office has issued a comprehensive patent to Posit Science for inventions utilizing brain training software to address depression, mood...
MYnd Analytics Announces Addition of Donald D’Ambrosio as Chief Financial Officer
April 03, 2017 08:30 ET
|
MYnd Analytics, Inc.
NEW YORK, April 03, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive medicine company which brings objective physical findings to psychiatric treatment in order to reduce...
MYnd Analytics Announces a Strategic One Million Dollar Equity Investment
March 21, 2017 08:30 ET
|
MYnd Analytics, Inc.
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive medicine company which brings objective physical findings to psychiatric treatment in order to reduce...
Hit Songwriter, Bestselling Author and Clinical Psychotherapist, Seth Swirsky, Set to Release '21 Ways to a Happier Depression' (Sourcebooks) -- a Creative, Watercolor-Filled, One-of-a-Kind Self Help Book
March 08, 2017 11:00 ET
|
Author Seth Swirsky
LOS ANGELES, CA--(Marketwired - March 08, 2017) - Seth Swirsky may already be on your radar if you love pop music. He wrote the #1 smash hit song, "Tell It To My Heart," for Taylor Dayne amongst many...